The FDA Advisory Committee Will Soon Review the NDA of Amylyx Pharmaceuticals' Product AMX0035 for ALS  

On September 7th the FDA Will Review Amylyx Pharmaceuticals NDA for ALS Treatment Amylyx Pharmaceuticals ( AMLX ) announced that the U.S. FDA Peripheral and Central Nervous System Advisory Committee (...